topotecan pliva
pliva pharma limited - topotecan hydrochloride - pdr/conc/soln for infus - 4 milligram
topotecan martindale pharma
martindale pharmaceuticals ltd - topotecan hydrochloride - pdr/conc/soln for infus - 1 milligram
topotecan martindale pharma
martindale pharmaceuticals ltd - topotecan hydrochloride - pdr/conc/soln for infus - 4 milligram
hycamtin
sandoz pharmaceuticals d.d. - topotecan - ovarian neoplasms; uterine cervical neoplasms; small cell lung carcinoma - antineoplastic agents - hycamtin capsules are indicated as monotherapy for the treatment of adult patients with relapsed small cell lung cancer (sclc) for whom re-treatment with the first-line regimen is not considered appropriate.topotecan is indicated for the treatment of patients with metastatic carcinoma of the ovary after failure of first-line or subsequent therapy.hycamtin capsules are indicated as monotherapy for the treatment of adult patients with relapsed small cell lung cancer (sclc) for whom re-treatment with the first-line regimen is not considered appropriate.
topotecan ebewe
ebewe pharma ges.m.b.h nfg. kg - topotecan hydrochloride - concentrate for soln for inf - 1 mg/ml
hycamtin topotecan (as hydrochloride) 1 mg hard capsules
novartis pharmaceuticals australia pty ltd - topotecan hydrochloride -
hycamtin topotecan (as hydrochloride) 0.25 mg hard capsules
novartis pharmaceuticals australia pty ltd - topotecan hydrochloride -
cipla-topotecan 1 mg
cipla - medpro (pty) ltd - topotecan hydrochloride - injection - each 5 ml injection vial contains topotecan hydrochloride equivalent to topotecan 1,0 mg
cipla-topotecan 4 mg
cipla - medpro (pty) ltd - topotecan hydrochloride - injection - each 10 ml injection vial contains topotecan hydrochloride equivalent to topotecan 4,0 mg
topotecanum accord 1 mg/ml, concentrate for solution for infusion
central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - concentrate for solution for infusion - topotecan hydrochloride 1 mg/ml - antineoplastic agents